Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
academic, appoximately, assemble, assembly, asymptomatic, BRAF, Bristol, buy, Canada, Cardiology, CeleNova, Centre, cerebral, China, complexity, consummation, Copenhagen, Covidian, customer, Dabrafenib, dabrafinib, DBC, DCTH, declined, declining, deferral, delisting, Denmark, director, disagreement, Distinguishing, Dutch, ease, efficiency, eleven, emerging, endedSeptember, fifty, formulation, freestanding, Genentech, GlaxoSmithKline, Harold, Hedging, hematologic, hereunder, honor, hundred, indefinite, instance, ipilimumab, irrevocably, ISO, issuer, iv, Japan, Koplewicz, Koplewiz, lab, lack, landscape, leucopenia, lieu, LUMC, lymphocytopenia, mandatorily, matter, MD, meaningful, media, Meijer, MEKINIST, Merit, mutation, NZA, Onyx, OTC, OTCQB, package, palliative, Peak, Pedder, physician, Queensbury, quickly, rapid, reallocated, reliability, requisite, resign, resigned, saline, sampling, seat, settlement, Simon, SirTex, Squibb, sterilization, sterilized, symbol, Tafinlar, trametinib, transcation, true, ultimately, Uveal, vacated, variable, vemurafenib, washout, Yervoy, Zelboraf, ZIN, ZL
Filing tables
Filing exhibits
DCTH similar filings
Filing view
External links